ICAR Presentation: "Muti-Pathway Development of Dual-Acting Pyrimidinedione NNRTIs as HIV Topical Microbicides"

April 7, 2012

Dr. Robert W. Buckheit Jr., President and CEO presented an oral presentation entitled "Muti-Pathway Development of Dual-Acting Pyrimidinedione NNRTIs as HIV Topical Microbicides" as part of the 25th International Conference on Antiviral Research in Sapporo, Japan. The presentation summarized the activity of the lead pyrimidinedione IQP-0528 and its development as a gel, film and a component of an intravaginal ring. In addition to the staff at ImQuest, the work was performed with collaborators Dr. Patrick Kiser at the University of Utah and Dr. Charlene Dezzutti at the University of Pittsburgh as part of a Integrated Preclincial/Clinical U19 grant funded by the NIH. IQP-0528 was licensed by ImQuest BioSciences in 2005 from Samjin Pharmaceutical Co. LTD in Seoul, Korea.

Return to Press Releases